Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Current Dermatology Reports
|
May 22, 2020
New Developments in Bacterial, Viral, and Fungal Cutaneous Infections
Samuel Yeroushalmi, Joshua Yoseph Shirazi, Adam Friedman
Complementary Therapies in Medicine
|
November 21, 2020
Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey
Samuel Yeroushalmi, Kamaria Nelson, Andrew Sparks, et al.
Journal of Telemedicine and Telecare
|
May 2, 2019
Telemedicine and multiple sclerosis: A comprehensive literature review
Samuel Yeroushalmi, Heidi Maloni, Kathleen Costello, et al.
JAAD International
|
October 17, 2022
Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS)
Samuel Yeroushalmi, Mimi Chung, Erin Bartholomew, et al.
Dermatology Online Journal
|
May 23, 2023
Improvement of psoriasis after initiation of antiviral therapy for hepatitis B
Mimi Chung, Marwa Hakimi, Samuel Yeroushalmi, et al.
The Journal of Dermatological Treatment
|
December 6, 2022
Comparing the odds of reported depression in psoriasis patients on systemic therapy: a cross-sectional analysis of postmarketing data
Samuel Yeroushalmi, Mimi Chung, Erin Bartholomew, et al.
Dermatology and Therapy
|
September 14, 2022
Mindfulness and Meditation for Psoriasis: A Systematic Review
Erin Bartholomew, Mimi Chung, Samuel Yeroushalmi, et al.
Psoriasis (Auckland, N.Z.)
|
June 30, 2022
Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives
Mimi Chung, Erin Bartholomew, Samuel Yeroushalmi, et al.
Psoriasis (Auckland, N.Z.)
|
July 11, 2022
Psoriasis and Exercise: A Review
Samuel Yeroushalmi, Marwa Hakimi, Mimi Chung, et al.
Expert Review of Clinical Immunology
|
August 5, 2022
A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis
Mimi Chung, Samuel Yeroushalmi, Marwa Hakimi, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Current Dermatology Reports
|
May 22, 2020
New Developments in Bacterial, Viral, and Fungal Cutaneous Infections
Samuel Yeroushalmi, Joshua Yoseph Shirazi, Adam Friedman
Complementary Therapies in Medicine
|
November 21, 2020
Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey
Samuel Yeroushalmi, Kamaria Nelson, Andrew Sparks, et al.
Journal of Telemedicine and Telecare
|
May 2, 2019
Telemedicine and multiple sclerosis: A comprehensive literature review
Samuel Yeroushalmi, Heidi Maloni, Kathleen Costello, et al.
JAAD International
|
October 17, 2022
Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS)
Samuel Yeroushalmi, Mimi Chung, Erin Bartholomew, et al.
Dermatology Online Journal
|
May 23, 2023
Improvement of psoriasis after initiation of antiviral therapy for hepatitis B
Mimi Chung, Marwa Hakimi, Samuel Yeroushalmi, et al.
The Journal of Dermatological Treatment
|
December 6, 2022
Comparing the odds of reported depression in psoriasis patients on systemic therapy: a cross-sectional analysis of postmarketing data
Samuel Yeroushalmi, Mimi Chung, Erin Bartholomew, et al.
Dermatology and Therapy
|
September 14, 2022
Mindfulness and Meditation for Psoriasis: A Systematic Review
Erin Bartholomew, Mimi Chung, Samuel Yeroushalmi, et al.
Psoriasis (Auckland, N.Z.)
|
June 30, 2022
Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives
Mimi Chung, Erin Bartholomew, Samuel Yeroushalmi, et al.
Psoriasis (Auckland, N.Z.)
|
July 11, 2022
Psoriasis and Exercise: A Review
Samuel Yeroushalmi, Marwa Hakimi, Mimi Chung, et al.
Expert Review of Clinical Immunology
|
August 5, 2022
A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis
Mimi Chung, Samuel Yeroushalmi, Marwa Hakimi, et al.
Page
of 3